AAAAAA

   
Results: 1-11 |
Results: 11
ERCC1 and thymidylate synthase mRNA levels predict survival for colorectalcancer patients receiving combination oxaliplatin and fluorouracil chemotherapy
Authors: Shirota, Y Stoehlmacher, J Brabender, J Xiang, YP Uetake, H Danenberg, KD Groshen, S Tsao-Wei, DD Danenberg, PV Lenz, HJ
Citation: Y. Shirota et al., ERCC1 and thymidylate synthase mRNA levels predict survival for colorectalcancer patients receiving combination oxaliplatin and fluorouracil chemotherapy, J CL ONCOL, 19(23), 2001, pp. 4298-4304
Carditis - A manifestation of gastroesophageal reflux disease
Authors: Der, R Tsao-Wei, DD Demeester, T Peters, J Groshen, S Lord, RVN Chandrasoma, P
Citation: R. Der et al., Carditis - A manifestation of gastroesophageal reflux disease, AM J SURG P, 25(2), 2001, pp. 245-252
Retinoic acid receptor-alpha messenger RNA expression is increased and retinoic acid receptor-gamma expression is decreased in Barrett's intestinal metaplasia, dysplasia, adenocarcinoma sequence
Authors: Lord, RVN Tsai, PI Danenberg, KD Peters, JH DeMeester, TR Tsao-Wei, DD Groshen, S Salonga, D Park, JM Crookes, PF Kiyabu, M Chandrasoma, P Danenberg, PV
Citation: Rvn. Lord et al., Retinoic acid receptor-alpha messenger RNA expression is increased and retinoic acid receptor-gamma expression is decreased in Barrett's intestinal metaplasia, dysplasia, adenocarcinoma sequence, SURGERY, 129(3), 2001, pp. 267-276
Increased c-myb mRNA expression in Barrett's esophagus and Barrett's-associated adenocarcinoma
Authors: Brabender, J Lord, RV Danenberg, KD Metzger, R Schneider, PM Park, JM Salonga, D Groshen, S Tsao-Wei, DD DeMeester, TR Holscher, AH Danenberg, PV
Citation: J. Brabender et al., Increased c-myb mRNA expression in Barrett's esophagus and Barrett's-associated adenocarcinoma, J SURG RES, 99(2), 2001, pp. 301-306
Treatment of patients with ovarian carcinoma with pegylated liposomal doxorubicin - Analysis of toxicities and predictors of outcome
Authors: Safra, T Groshen, S Jeffers, S Tsao-Wei, DD Zhou, LY Muderspach, L Roman, L Morrow, CP Burnett, A Muggia, FM
Citation: T. Safra et al., Treatment of patients with ovarian carcinoma with pegylated liposomal doxorubicin - Analysis of toxicities and predictors of outcome, CANC CYTOP, 91(1), 2001, pp. 90-100
Treatment of patients with ovarian carcinoma with pegylated liposomal doxorubicin - Analysis of toxicities and predictors of outcome
Authors: Safra, T Groshen, S Jeffers, S Tsao-Wei, DD Zhou, LY Muderspach, L Roman, L Morrow, CP Burnett, A Muggia, FM
Citation: T. Safra et al., Treatment of patients with ovarian carcinoma with pegylated liposomal doxorubicin - Analysis of toxicities and predictors of outcome, CANCER, 91(1), 2001, pp. 90-100
Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase
Authors: Salonga, D Danenberg, KD Johnson, M Metzger, R Groshen, S Tsao-Wei, DD Lenz, HJ Leichman, CG Leichman, L Diasio, RB Danenberg, PV
Citation: D. Salonga et al., Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase, CLIN CANC R, 6(4), 2000, pp. 1322-1327
Pegylated liposomal doxorubicin (doxil): Reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m(2)
Authors: Safra, T Muggia, F Jeffers, S Tsao-Wei, DD Groshen, S Lyass, O Henderson, R Berry, G Gabizon, A
Citation: T. Safra et al., Pegylated liposomal doxorubicin (doxil): Reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m(2), ANN ONCOL, 11(8), 2000, pp. 1029-1033
LEA.135 expression: its comparison with other prognostic biomarkers for patients with primary breast carcinoma
Authors: Liu, DX Baltayan, A Naritoku, WY Barr, NJ Young, LL Chaiwun, B Tsao-Wei, DD Groshen, SL Taylor, CR Torloni, H Neville, AM Cote, RJ Imam, SA
Citation: Dx. Liu et al., LEA.135 expression: its comparison with other prognostic biomarkers for patients with primary breast carcinoma, ANTICANC R, 20(3A), 2000, pp. 1451-1461
Update on impact of moderate dose of adjuvant radiation on urinary continence and sexual potency in prostate cancer patients treated with nerve-sparing prostatectomy
Authors: Formenti, SC Lieskovsky, G Skinner, D Tsao-Wei, DD Groshen, S Petrovich, Z
Citation: Sc. Formenti et al., Update on impact of moderate dose of adjuvant radiation on urinary continence and sexual potency in prostate cancer patients treated with nerve-sparing prostatectomy, UROLOGY, 56(3), 2000, pp. 453-458
Follicular lesions of thyroid - A 5-year fine-needle aspiration experience
Authors: Greaves, TS Olvera, M Florentine, BD Raza, AS Cobb, CJ Tsao-Wei, DD Groshen, S Singer, P Lopresti, J Martin, SE
Citation: Ts. Greaves et al., Follicular lesions of thyroid - A 5-year fine-needle aspiration experience, CANC CYTOP, 90(6), 2000, pp. 335-341
Risultati: 1-11 |